Aurobindo Dicyclomine Hydrochloride 10mg capsules recalled for empty capsules
Aurobindo Pharma USA is recalling Dicyclomine Hydrochloride Capsules 10mg (Batch DMC125018A, expiration 07/2027) because some bottles contain empty capsules instead of the medication. The issue affects approximately 6,408 bottles distributed nationwide.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have Dicyclomine from this batch (look for NDC 59651-719-99 and batch number DMC125018A on the label).
- Do not take capsules from an affected bottle.
- Contact your pharmacy or doctor for a replacement or alternative medication.
- Return the affected bottle to your pharmacy.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 6,408 bottles distributed to market
- Illnesses reported
- None reported
- Manufactured in
- 279 Princeton Hightstown Rd, East Windsor, NJ, United States
- Classification
- Class II
- Recall number
- D-0733-2026
In the FDA's words
- Description
- Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 shortfill; reports of empty capsules. Batch # DMC125018A, Exp Date: 07/2027. Distribution: US Nationwide. Affected quantity: 6,408 bottles distributed to market
- Hazard
- shortfill; reports of empty capsules.